Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind Parallel Comparison Study of SR25990C Versus Standard Therapy in Japan(Ticlopidine) in Patients With Acute Coronary Syndrome Without ST-Segment Elevation Who Are Planned for Percutaneous Coronary Intervention

NCT00325390 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00325390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00325390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind Parallel Comparison Study of SR25990C Versus Standard Therapy in Japan(Ticlopidine) in Patients With Acute Coronary Syndrome Without ST-Segment Elevation Who Are Planned for Percutaneous Coronary Intervention
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2004
Completion date
Not reported
Enrollment
800
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nsteacs, platelet aggregation inhibitors